Immunohistochemical analysis using mutation-specific VE-1 antibody on tissue microarrays is a feasible, time-efficient and cost-efficient approach to high-throughput screening for BRAF V600E mutations in large brain tumor series and metastases. The gene discussed is BRAF; the disease is brain neoplasm.